GENE EXPRESSION ANALYSIS OF BONE METASTASIS AND CIRCULATING TUMOR CELLS FROM METASTATIC CASTRATE-RESISTANT PROSTATE CANCER PATIENTS

被引：0
|
作者：
Cho, Won-Jin
Cher, Michael
Oliveira, Daniel
Najy, Abdo
Mainetti, Leandro
Heath, Elisabeth
Hyeong-Reh, Kim
Bonfil, R. Daniel
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.687
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD32-11
引用
收藏
页码：E764 / E765
页数：2
相关论文
共 50 条
  • [41] Blood-based gene expression profiling in castrate-resistant prostate cancer
    Gross, Mitchell E.
    [J]. BMC MEDICINE, 2015, 13
  • [42] Non-enrichment based method for analysis of androgen receptor expression in circulating tumor cells (CTCs) in patients with metastatic castrate resistant prostate cancer
    Gross, Mitchell E.
    Lazar, Daniel C.
    Cho, Edward H.
    Luttgen, Madelyn
    Uson, Maria L.
    Kuhn, Peter
    Torrey, Melissa L.
    [J]. CANCER RESEARCH, 2012, 72
  • [43] Re: Novel Therapies for Metastatic Castrate-Resistant Prostate Cancer
    Sartor, Oliver
    Parker, Chris
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (09) : 717 - 717
  • [44] Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer
    Pal, Sumanta K.
    Lewis, Brian
    Sartor, Oliver
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 583 - +
  • [45] Refining the use of cabazitaxel in metastatic castrate-resistant prostate cancer
    Culine, Stephane
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 97 : 30 - 32
  • [46] Blood-based gene expression profiling in castrate-resistant prostate cancer
    Mitchell E. Gross
    [J]. BMC Medicine, 13
  • [47] Novel prostate cancer patient-derived xenograft models of bone metastatic castrate-resistant prostate cancer
    Jamieson, Christina
    Wu, Christina
    Strasner, Amy
    Woo, Jason R.
    Muldong, Michelle
    Jeong, Young B.
    Liss, Michael A.
    Raheem, Omer
    Yamaguchi, Tomonori
    Leu, Heather
    Marshall, Deborah
    Morris, Sheldon
    Cacalano, Nicholas A.
    Masuda, Koichi
    Jamieson, Catriona H. M.
    Kulidjian, Anna A.
    Kane, Christopher J.
    [J]. MOLECULAR CANCER RESEARCH, 2014, 12
  • [48] Feasibility of multimodal molecular characterization of the androgen receptor (AR) in circulating tumor cells (CTCs) from patients with castrate-resistant prostate cancer (CRPC).
    VanderWeele, David James
    Isikbay, Masis
    Reyes, Edwin
    Duggan, Ryan
    Wyche, Alicia J.
    Stadler, Walter Michael
    Vander Griend, Donald
    Szmulewitz, Russell Zelig
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [49] Current perspectives on bone metastases in castrate-resistant prostate cancer
    Christopher Logothetis
    Michael J. Morris
    Robert Den
    Robert E. Coleman
    [J]. Cancer and Metastasis Reviews, 2018, 37 : 189 - 196
  • [50] Association of elevated serum CEA with visceral metastasis and distinctive circulating tumor DNA alterations in castrate-resistant prostate cancer.
    Bray, Alexander
    Malalur, Pannaga G.
    Drusbosky, Leylah
    Gourdin, Theodore Stewart
    Lilly, Michael B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345